124 related articles for article (PubMed ID: 19804839)
1. A cell-based assay for screening lipoxygenase inhibitors.
Nair DG; Funk CD
Prostaglandins Other Lipid Mediat; 2009 Dec; 90(3-4):98-104. PubMed ID: 19804839
[TBL] [Abstract][Full Text] [Related]
2. Development of a fluorescence-based enzyme assay of human 5-lipoxygenase.
Pufahl RA; Kasten TP; Hills R; Gierse JK; Reitz BA; Weinberg RA; Masferrer JL
Anal Biochem; 2007 May; 364(2):204-12. PubMed ID: 17376394
[TBL] [Abstract][Full Text] [Related]
3. 5-LOX inhibitor modulates the inflammatory responses provoked by Helicobacter pylori infection.
Park S; Han SU; Lee KM; Park KH; Cho SW; Hahm KB
Helicobacter; 2007 Feb; 12(1):49-58. PubMed ID: 17241301
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
Masferrer JL; Zweifel BS; Hardy M; Anderson GD; Dufield D; Cortes-Burgos L; Pufahl RA; Graneto M
J Pharmacol Exp Ther; 2010 Jul; 334(1):294-301. PubMed ID: 20378715
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor.
Takeda S; Usami N; Yamamoto I; Watanabe K
Drug Metab Dispos; 2009 Aug; 37(8):1733-7. PubMed ID: 19406952
[TBL] [Abstract][Full Text] [Related]
6. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival.
Tang DG; Honn KV
J Cell Physiol; 1997 Aug; 172(2):155-70. PubMed ID: 9258337
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
9. Biologic relevance of lipoxygenase isoforms in atherogenesis.
Kuhn H
Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1099-110. PubMed ID: 16293000
[TBL] [Abstract][Full Text] [Related]
10. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
Ding XZ; Kuszynski CA; El-Metwally TH; Adrian TE
Biochem Biophys Res Commun; 1999 Dec; 266(2):392-9. PubMed ID: 10600514
[TBL] [Abstract][Full Text] [Related]
11. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modeling and virtual screening for designing potential 5-lipoxygenase inhibitors.
Aparoy P; Kumar Reddy K; Kalangi SK; Chandramohan Reddy T; Reddanna P
Bioorg Med Chem Lett; 2010 Feb; 20(3):1013-8. PubMed ID: 20045317
[TBL] [Abstract][Full Text] [Related]
13. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
14. Effect of the interaction between lipoxygenase pathway and progesterone on the regulation of hydroxysteroid 11-Beta dehydrogenase 2 in cultured human term placental trophoblasts.
Sato K; Chisaka H; Okamura K; Challis JR
Biol Reprod; 2008 Mar; 78(3):514-20. PubMed ID: 18032417
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of lipoxygenase inhibitors on murine bladder cancer cell line (MBT-2).
Ikemoto S; Sugimura K; Kuratukuri K; Nakatani T
Anticancer Res; 2004; 24(2B):733-6. PubMed ID: 15161019
[TBL] [Abstract][Full Text] [Related]
17. Regulation of lipoxygenase activity by polyunsaturated lysophosphatidylcholines or their oxygenation derivatives.
Huang LS; Kim MR; Sok DE
J Agric Food Chem; 2008 Sep; 56(17):7808-14. PubMed ID: 18680379
[TBL] [Abstract][Full Text] [Related]
18. Development of a new colorimetric assay for lipoxygenase activity.
Lu W; Zhao X; Xu Z; Dong N; Zou S; Shen X; Huang J
Anal Biochem; 2013 Oct; 441(2):162-8. PubMed ID: 23811155
[TBL] [Abstract][Full Text] [Related]
19. Lipoxygenase inhibitors prevent urological cancer cell growth.
Matsuyama M; Yoshimura R; Tsuchida K; Takemoto Y; Segawa Y; Shinnka T; Kawahito Y; Sano H; Nakatani T
Int J Mol Med; 2004 May; 13(5):665-8. PubMed ID: 15067367
[TBL] [Abstract][Full Text] [Related]
20. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
